Search

The authors suggest that the U.S. Congress can help the Defense Contract Audit Agency (DCAA) by giving the agency more resources, rather than castigating it. They cite several issues against the DCAA, such as the failure of the agency to provide enough resources to audits of contractors who received clean bills of health. They assert that the agency continues to be a tough auditor that performs quality oversight on the most aberrant of defense contractors. They emphasize the intensified audit work of the DCAA with contractors and contracting officers.

The author emphasizes the need for the U.S. federal government contracting community to acknowledge the truth to the image shown in the media which reveals contracting as wasteful and unaccountable practice. He stresses the need for reform in the government contracting system. He attributes the distressing condition of such system to the changes in policy that have hindered contracting officers from performing cost and price analysis and effective contract negotiations.

Matt Jennings and James Scozzie are president and senior vice-president, respectively, of BioEnterprise Corp. If BioEnterprise attracts just a few more bioscience companies to Northeast Ohio, the economic impact would far exceed that of James. Bioscience businesses end up employing thousands of people and improving the economic fortunes of tens of thousands of area families. For example, founded in 1995 through BioEnterprise's incubator, Athersys Inc. got international attention when it created the world's first artificial chromosome in 1997. Bioscience earnings are estimated to reach $750 billion a year in the next several years.